New Delhi [India], July 5 (ANI): US giant drug maker Moderna's Covid-19 messenger RNA (mRNA) vaccine is expected to reach India this week after the completion of some official formalities, informed sources.
New Delhi [India], July 5 (ANI): India will offer the CoWIN platform as a digital public platform to other countries to run their own COVID-19 vaccination drives to fight the pandemic, Prime Minister Narendra Modi announced on Monday at the CoWIN Global Conclave.
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
New Delhi [India], July 1 (ANI): The central government's Subject Expert Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik Light in India.
New Delhi [India], June 30 (ANI): Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday.
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon.
New Delhi [India], June 30 (ANI): Results of trials of the third booster dose of Bharat Biotech's COVID-19 vaccine Covaxin is expected to come by November this year, sources told ANI.
New Delhi [India], June 28 (ANI): In another significant COVID-19 vaccination milestone, India has overtaken the United States of America in the total number of vaccine doses administered so far, the union health ministry informed on Monday.
New Delhi [India], June 25 (ANI): As many as 50 cases of Delta Plus variant of COVID-19 have been recorded across 11 states in India, government sources said on Friday.
New Delhi [India], June 24 (ANI): It is too early to say whether Delta Plus, the new mutant version of the Delta strain of COVID-19 first detected in India and labelled as a "variant of concern" by the Centre will be responsible for a third wave of Coronavirus, which according to experts
Moscow [Russia], June 24 (ANI): The World Health Organization (WHO) has raised concerns over a manufacturing plant responsible for filling the vials with the Sputnik V COVID-19 vaccine.
New Delhi [India], June 23 (ANI): AIIMS Delhi Director Dr Randeep Guleria has said that appropriate behaviour, good surveillance and vaccination are important to avoid the third wave of COVID-19 and noted that mutation of the virus is a matter of concern.